XCUR
Exicure Inc
NASDAQ: XCUR · HEALTHCARE · BIOTECHNOLOGY
$3.36
+1.51% today
Updated 2026-04-30
Market cap
$22.12M
P/E ratio
—
P/S ratio
13.61x
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$3 – $12
Volume
0.0M
Exicure Inc (XCUR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-92.50%
ROA
-43.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $2.39M | $-13.15M | -323.95% | -550.42% | -550.71% |
| 2016 | $1.04M | $-16.94M | -1,218.44% | -1,560.04% | -1,635.23% |
| 2017 | $9.72M | $-11.01M | -34.58% | -107.08% | -113.29% |
| 2018 | $118000.00 | $-22.41M | 100.00% | -18,490.68% | -18,994.07% |
| 2019 | $1.30M | $-26.30M | 100.00% | -2,053.78% | -2,029.55% |
| 2020 | $16.61M | $-24.67M | -93.19% | -153.11% | -148.49% |
| 2021 | $-483000.00 | $-64.10M | 100.00% | 12,950.10% | 13,271.64% |
| 2022 | $28.83M | $-2.58M | 93.56% | -6.35% | -8.96% |
| 2023 | $0.00 | $-16.91M | — | — | — |
| 2024 | $500000.00 | $-9.70M | 100.00% | -2,446.40% | -1,940.20% |
| 2025 | $0.00 | $-4.95M | — | — | — |